Related by context. Frequent words. (Click for all words.) 57 Merck Schering Plough 54 Genentech Roche 53 deforolimus 53 muraglitazar 52 faropenem 52 Encysive Pharmaceuticals 52 spokesman Tony Plohoros 52 Adventrx 52 Co MRK 51 elotuzumab 51 spokesman Doug Petkus 50 Shedlarz 50 AstraZeneca plc 50 Dainippon Sumitomo 50 Roche Holding AG RHHBY 50 Schering Plough NYSE SGP 50 Advinus 50 Pfizer Wyeth 50 vorapaxar 50 Aegerion 50 Abbott ABT 50 Oscient Pharmaceuticals 50 AstraZeneca Crestor 49 ridaforolimus 49 GlaxoSmithKline PLC GSK 49 Kyowa Hakko Kogyo 49 AstraZeneca 49 Aventis Behring 49 Merck 49 Fablyn 49 Pfizer PFE.N 49 Cardiokine 49 Caduet 49 Ixempra 49 AstraZeneca AZN 49 AstraZeneca PLC AZN 49 ReoPro 49 Penwest Pharmaceuticals 49 Xanodyne 49 TranSwitch indebtedness 49 Reicin 49 outlicensing 48 Bristol Myers Squibb 48 obj obj = 48 By Dennis Rockstroh 48 Pfizer 48 taranabant 48 PTK ZK 48 Therein lurks 48 ZETIA 48 efficacy tolerability 48 TriLipix 48 MicroDose 48 Recentin 48 Ronald W. Dollens 48 Bristol Myers Squibb BMY.N 48 pharmacodynamic effects 48 Trilipix 48 spokeswoman Julie Zawisza 48 BioSeek 48 Emend 48 Bristol Myers 48 Novartis NOVN.VX 48 pharmacoeconomic 48 Parexel 48 Mitigation Strategy REMS 48 Teva Pharma 48 Biogen IDEC 47 Alnara 47 Teva Pharmaceutical TEVA 47 Arxxant 47 Takeda Pharmaceutical Co 47 Galida 47 Indiplon 47 ocrelizumab 47 By Tom Polansek 47 loratadine 47 Pargluva 47 Inpharmatica 47 Takeda Pharmaceutical Co. 47 Nexavar ® 47 Cladribine 47 Daiichi Pharmaceutical 47 Pfizer Inc PFE.N 47 NovaCardia 47 Vimovo 47 TAP Pharmaceuticals 47 Arixtra 47 PsychoGenics 47 Inspra 47 Zalbin 47 GLPG# 47 approvability 47 Bayer Schering 47 GlaxoSmithKline 47 Somaxon Pharmaceuticals 47 Bristol Myers Squibb BMY 47 Promacta 47 betrixaban 47 Funtleyder 46 Ray Kerins